CEVAXEL Trademark

Trademark Overview

On Thursday, August 22, 2013, a trademark application was filed for CEVAXEL with the United States Patent and Trademark Office. The USPTO has given the CEVAXEL trademark a serial number of 79136024. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, August 22, 2023. The CEVAXEL trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infective products for veterinary use
cevaxel

General Information

Serial Number79136024
Word MarkCEVAXEL
Filing DateThursday, August 22, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, August 22, 2023
Registration Number4490089
Registration DateTuesday, March 4, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2013

Trademark Statements

Goods and ServicesAnti-infective products for veterinary use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

NOT AVAILABLE

Trademark Events

Event DateEvent Description
Sunday, March 10, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, March 10, 2024DEATH OF INTERNATIONAL REGISTRATION
Saturday, June 18, 2022NEW REPRESENTATIVE AT IB RECEIVED
Sunday, April 10, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, March 4, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, March 4, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Monday, March 4, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, March 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 1, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 1, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 1, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, July 11, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 11, 2014FINAL DISPOSITION PROCESSED
Wednesday, June 4, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 4, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, December 17, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2013PUBLISHED FOR OPPOSITION
Sunday, December 15, 2013NOTIFICATION PROCESSED BY IB
Thursday, November 28, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 27, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 27, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 12, 2013ASSIGNED TO LIE
Monday, October 28, 2013REFUSAL PROCESSED BY IB
Thursday, October 24, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 23, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 23, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 9, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 9, 2013REFUSAL PROCESSED BY MPU
Wednesday, October 9, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 9, 2013APPLICATION FILING RECEIPT MAILED
Tuesday, October 8, 2013NON-FINAL ACTION WRITTEN
Tuesday, October 8, 2013ASSIGNED TO EXAMINER
Saturday, October 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 30, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, September 27, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

cevaxel veterinary products infective anti